PL369235A1 - Kompozycja wybranych opioidów z substancjami antagonistycznymi względem muskaryny do leczenia nietrzymania moczu - Google Patents

Kompozycja wybranych opioidów z substancjami antagonistycznymi względem muskaryny do leczenia nietrzymania moczu

Info

Publication number: PL369235A1
Authority: PL; Poland
Prior art keywords: urinary incontinence; combination; treating urinary; opioids; muscarine antagonists
Prior art date: 2001-09-18

Application number

PL02369235A

Other languages

English (en)

Other versions

PL209272B1 (pl

Inventor

Thomas Christoph

Original Assignee

Grünenthal GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-18

Filing date

2002-09-18

Publication date

2005-04-18

2002-09-18 Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH

2005-04-18 Publication of PL369235A1 publication Critical patent/PL369235A1/pl

2011-08-31 Publication of PL209272B1 publication Critical patent/PL209272B1/pl

Links

206010046543 Urinary incontinence Diseases 0.000 title abstract 3
229940005483 opioid analgesics Drugs 0.000 title abstract 2
UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 3
239000002253 acid Substances 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
PZNRRUTVGXCKFC-IUODEOHRSA-N (2r,3r)-1-(dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol Chemical compound CN(C)C[C@@H](C)[C@](O)(CC)C1=CC=CC(OC)=C1 PZNRRUTVGXCKFC-IUODEOHRSA-N 0.000 abstract 1
XIQVNETUBQGFHX-UHFFFAOYSA-N Ditropan Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCC#CCN(CC)CC)C1CCCCC1 XIQVNETUBQGFHX-UHFFFAOYSA-N 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229960005434 oxybutynin Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL369235A 2001-09-18 2002-09-18 Kompozycja substancji czynnych zawierająca pochodną 1-fenylo-3-dwumetyloaminopropanu i jej zastosowanie oraz środek leczniczy PL209272B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10146275A DE10146275A1 (de)	2001-09-18	2001-09-18	Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

Publications (2)

Publication Number	Publication Date
PL369235A1 true PL369235A1 (pl)	2005-04-18
PL209272B1 PL209272B1 (pl)	2011-08-31

Family

ID=7699618

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL369235A PL209272B1 (pl)	2001-09-18	2002-09-18	Kompozycja substancji czynnych zawierająca pochodną 1-fenylo-3-dwumetyloaminopropanu i jej zastosowanie oraz środek leczniczy

Country Status (21)

Country	Link
US (2)	US20040242617A1 (pl)
EP (1)	EP1429754B1 (pl)
JP (1)	JP4511176B2 (pl)
KR (1)	KR100891438B1 (pl)
CN (1)	CN100384413C (pl)
AT (1)	ATE383854T1 (pl)
AU (1)	AU2002342707B2 (pl)
BR (1)	BR0212714A (pl)
CA (1)	CA2460655C (pl)
DE (2)	DE10146275A1 (pl)
EC (1)	ECSP045025A (pl)
ES (1)	ES2299608T3 (pl)
HU (1)	HUP0401485A3 (pl)
IL (2)	IL160894A0 (pl)
MX (1)	MXPA04002510A (pl)
NO (1)	NO333016B1 (pl)
NZ (1)	NZ531777A (pl)
PL (1)	PL209272B1 (pl)
RU (1)	RU2305562C2 (pl)
WO (1)	WO2003024444A1 (pl)
ZA (1)	ZA200402853B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10146275A1 (de)	2001-09-18	2003-04-24	Gruenenthal Gmbh	Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
DE10224108A1 (de) *	2002-05-29	2004-01-29	Grünenthal GmbH	1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung
US7410965B2 (en)	2002-05-29	2008-08-12	Gruenenthal Gmbh	Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol
DE10224556A1 (de) *	2002-05-31	2004-01-08	Grünenthal GmbH	1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
ES2288641T3 (es) *	2002-12-20	2008-01-16	Dynogen Pharmaceuticals Inc.	Metodo para tratar trastornos indoloros de la vejiga usando moduladores de canales del calcio de la subunidad alfa2-delta.
DE602004003172T2 (de) *	2003-03-21	2007-09-27	Dynogen Pharmaceuticals Inc., Waltham	Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
DE10356362A1 (de) *	2003-11-28	2005-06-23	Grünenthal GmbH	Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen
AU2005245403B2 (en) *	2004-05-14	2012-04-19	Janssen Pharmaceutica N.V.	Carboxamido opioid compounds
DE102005009217A1 (de) *	2005-02-25	2006-08-31	Grünenthal GmbH	Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen
US20070032551A1 (en) *	2005-07-22	2007-02-08	Gruenenthal Gmbh	Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
JP5323480B2 (ja) *	2005-07-22	2013-10-23	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	３−［２−（ジメチルアミノ）メチル−（シクロヘキシ−１−イル）］−フェノールのＨＣｌ多形体
US7884247B2 (en) *	2005-07-22	2011-02-08	Gruenenthal Gmbh	Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof
DE102007022790A1 (de)	2007-05-11	2008-11-20	Grünenthal GmbH	Axomadol zur Schmerzbehandlung bei Arthrose
BRPI0921725A2 (pt) *	2008-10-30	2016-01-05	Grüenthal GmbH	formas de dosagem potentes do tapentadol
WO2011110595A1 (de)	2010-03-10	2011-09-15	Grünenthal GmbH	Kristalline salze und/oder cokristalle von o-desmethyltramadol
CA2798884C (en)	2010-05-10	2016-09-13	Euro-Celtique S.A.	Manufacturing of active-free granules and tablets comprising the same
AU2011252039B2 (en)	2010-05-10	2014-06-12	Euro-Celtique S.A.	Pharmaceutical compositions comprising hydromorphone and naloxone
CN103002881B (zh)	2010-05-10	2015-09-02	欧洲凯尔特公司	载有活性剂的颗粒与额外活性剂的组合
CN103040828B (zh) *	2013-01-07	2015-12-02	常州康普药业有限公司	复方地芬诺酯片及其制备方法
WO2015071380A1 (en)	2013-11-13	2015-05-21	Euro-Celtique S.A.	Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
US11977085B1 (en)	2023-09-05	2024-05-07	Elan Ehrlich	Date rape drug detection device and method of using same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB857194A (en) *	1957-07-05	1960-12-29	Clinical Products Ltd	Therapeutic agents comprising ion-exchange resins
NL127065C (pl)	1964-04-22
US5736577A (en)	1995-01-31	1998-04-07	Sepracor, Inc.	Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
DE3012837A1 (de) *	1979-04-10	1980-10-30	Sandoz Ag	Analgetische und myotonolytische praeparate
DE3129982A1 (de) *	1981-07-29	1983-02-17	Jutta 8200 Rosenheim Meyer	"antiallergikum"
US5073560A (en)	1990-07-20	1991-12-17	Fisons Corporation	Spiro-isoxazolidine derivatives as cholinergic agents
DE4041559A1 (de)	1990-12-22	1992-06-25	Boehringer Ingelheim Kg	Neue wirkstoffkombinationen
SE9202218D0 (sv) *	1992-07-22	1992-07-22	Kabi Pharmacia Ab	Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
CN1054850C (zh) *	1993-07-30	2000-07-26	德尔塔药物公司	用于治疗的哌嗪化合物
DE4426245A1 (de)	1994-07-23	1996-02-22	Gruenenthal Gmbh	1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DE69631525T2 (de) *	1995-03-03	2004-12-16	Endo Pharmaceuticals Inc.	Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz
DE19525137C2 (de)	1995-07-11	2003-02-27	Gruenenthal Gmbh	6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) *	1996-03-13	1997-09-18	Gruenenthal Gmbh	Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
JP2000515525A (ja)	1996-07-19	2000-11-21	アベーグ，グンナー	尿と胃腸の疾患の治療におけるｓ（―）―トルテロジン
EP1005861B1 (en) *	1997-04-11	2005-06-29	Nippon Shinyaku Co., Ltd.	Remedies for frequent urination and urinary incontinence
PE20010623A1 (es) *	1999-10-05	2001-07-07	Gruenenthal Chemie	Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
PT1257277E (pt) *	2000-02-24	2005-09-30	Pharmacia & Upjohn Co Llc	Novas combinacoes de farmacos
DE10059412A1 (de) *	2000-11-30	2002-06-13	Gruenenthal Gmbh	Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de)	2001-09-18	2003-04-24	Gruenenthal Gmbh	Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

2001
- 2001-09-18 DE DE10146275A patent/DE10146275A1/de not_active Withdrawn
2002
- 2002-09-18 PL PL369235A patent/PL209272B1/pl unknown
- 2002-09-18 DE DE50211566T patent/DE50211566D1/de not_active Expired - Lifetime
- 2002-09-18 CN CNB028227794A patent/CN100384413C/zh not_active Expired - Fee Related
- 2002-09-18 KR KR1020047004002A patent/KR100891438B1/ko not_active Expired - Fee Related
- 2002-09-18 CA CA2460655A patent/CA2460655C/en not_active Expired - Fee Related
- 2002-09-18 AT AT02779368T patent/ATE383854T1/de active
- 2002-09-18 AU AU2002342707A patent/AU2002342707B2/en not_active Ceased
- 2002-09-18 HU HU0401485A patent/HUP0401485A3/hu unknown
- 2002-09-18 JP JP2003528540A patent/JP4511176B2/ja not_active Expired - Fee Related
- 2002-09-18 EP EP02779368A patent/EP1429754B1/de not_active Expired - Lifetime
- 2002-09-18 ES ES02779368T patent/ES2299608T3/es not_active Expired - Lifetime
- 2002-09-18 MX MXPA04002510A patent/MXPA04002510A/es active IP Right Grant
- 2002-09-18 WO PCT/EP2002/010460 patent/WO2003024444A1/de not_active Ceased
- 2002-09-18 RU RU2004111788/15A patent/RU2305562C2/ru not_active IP Right Cessation
- 2002-09-18 BR BR0212714-8A patent/BR0212714A/pt not_active Application Discontinuation
- 2002-09-18 IL IL16089402A patent/IL160894A0/xx unknown
- 2002-09-18 NZ NZ531777A patent/NZ531777A/en not_active IP Right Cessation
2004
- 2004-03-12 NO NO20041059A patent/NO333016B1/no not_active IP Right Cessation
- 2004-03-16 IL IL160894A patent/IL160894A/en not_active IP Right Cessation
- 2004-03-17 EC EC2004005025A patent/ECSP045025A/es unknown
- 2004-03-18 US US10/803,187 patent/US20040242617A1/en not_active Abandoned
- 2004-04-15 ZA ZA2004/02853A patent/ZA200402853B/en unknown
2011
- 2011-09-23 US US13/242,672 patent/US8946290B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2460655A1 (en)	2003-03-27
CN100384413C (zh)	2008-04-30
WO2003024444A1 (de)	2003-03-27
HUP0401485A3 (en)	2008-04-28
DE50211566D1 (de)	2008-03-06
NZ531777A (en)	2006-11-30
IL160894A0 (en)	2004-08-31
ATE383854T1 (de)	2008-02-15
ES2299608T3 (es)	2008-06-01
KR100891438B1 (ko)	2009-04-03
RU2004111788A (ru)	2005-06-10
EP1429754B1 (de)	2008-01-16
JP4511176B2 (ja)	2010-07-28
AU2002342707B2 (en)	2006-10-12
EP1429754A1 (de)	2004-06-23
NO20041059L (no)	2004-05-12
RU2305562C2 (ru)	2007-09-10
BR0212714A (pt)	2004-08-03
ZA200402853B (en)	2005-02-23
HUP0401485A2 (hu)	2004-11-29
NO333016B1 (no)	2013-02-18
HK1075205A1 (zh)	2005-12-09
JP2005507387A (ja)	2005-03-17
DE10146275A1 (de)	2003-04-24
US20120016023A1 (en)	2012-01-19
ECSP045025A (es)	2004-04-28
KR20040044953A (ko)	2004-05-31
US8946290B2 (en)	2015-02-03
IL160894A (en)	2010-04-29
MXPA04002510A (es)	2004-05-31
CA2460655C (en)	2012-02-07
US20040242617A1 (en)	2004-12-02
CN1589140A (zh)	2005-03-02
PL209272B1 (pl)	2011-08-31

Publication	Publication Date	Title
IL160894A0 (en)	2004-08-31	Combination of selected opioids with muscarine antagonists for treating urinary incontinence
BR0114799A (pt)	2003-12-30	Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
WO2006066879A3 (en)	2006-10-12	Compounds with kv4 ion channel activity
CA2366702A1 (en)	2000-10-12	Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
EP2275107A3 (en)	2013-06-26	Combinations for the treatment of diseases involving cell proliferation
YU71901A (sh)	2005-07-19	NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
WO2006093348A3 (en)	2006-11-16	Method and composition for treating peripheral vascular diseases
EP1933833B8 (en)	2011-09-14	Therapy for the treatment of overactive bladder
MY125414A (en)	2006-07-31	Aminopropylphosphinic acids
HUP0401192A3 (en)	2005-07-28	Use of photosenzitizing agent for preparation ot, of pharmaceutical composition for treating wounds
EP2767291A3 (en)	2014-10-08	Treatment of glycogen storage disease type II
EA200800161A1 (ru)	2008-06-30	Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
DE60134245D1 (de)	2008-07-10	(5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
GB0112348D0 (en)	2001-07-11	Compounds
BRPI0508579A (pt)	2007-08-14	composto, composição farmacêutica, e, uso de um composto
WO2002030467A3 (en)	2002-10-24	Pharmaceutical composition containing honey for the treatment of wounds
IL162384A0 (en)	2005-11-20	Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
HK1047707A1 (zh)	2003-03-07	(+)-曲马朵、o-去甲曲马朵或(+)-o-去甲曲马朵、o-去甲-n-单-去甲-曲马朵或(+)-o-去甲-n-单-去甲-曲马朵治疗尿失禁的用途
TW200505408A (en)	2005-02-16	Agent for preventing and/or treating tissue disruption-accompanied diseases
TW200501963A (en)	2005-01-16	Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
BR0315247A (pt)	2005-08-30	Composição, composição farmacêutica, método de tratamento para uma doença proliferativa celular, e, kit
MXPA05008711A (es)	2005-10-05	Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
AU2001246388A1 (en)	2001-10-15	Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine
WO2002055022A3 (en)	2003-02-27	Active metabolite of antifungal compound
IL156140A0 (en)	2003-12-23	Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence